Line 18: | Line 18: | ||
.homePageButton { | .homePageButton { | ||
− | |||
border-radius: 0.8em; | border-radius: 0.8em; | ||
font-family: "arial black"; | font-family: "arial black"; | ||
Line 52: | Line 51: | ||
<br>cancer antigen -“Neoantigen”.<br></div> | <br>cancer antigen -“Neoantigen”.<br></div> | ||
<center> | <center> | ||
− | <a href="/Team:Tongji_China/Background"><button class="homePageButton">Background</button></a> | + | <a href="/Team:Tongji_China/Background"><button class="homePageButton" style="background-color:#A8A96B;">Background</button></a> |
</center> | </center> | ||
</div> | </div> | ||
Line 65: | Line 64: | ||
<br>oral intake.<br></div> | <br>oral intake.<br></div> | ||
<center> | <center> | ||
− | <a href="/Team:Tongji_China/Design"><button class="homePageButton">Design</button></a> | + | <a href="/Team:Tongji_China/Design"><button class="homePageButton"style="background-color:#91AFAD;">Design</button></a> |
− | <a href="/Team:Tongji_China/Description"><button class="homePageButton">Description</button></a> | + | <a href="/Team:Tongji_China/Description"><button class="homePageButton"style="background-color:#8BADC1;">Description</button></a> |
</center> | </center> | ||
</div> | </div> | ||
Line 77: | Line 76: | ||
<br>efficiently and safely.<br></div> | <br>efficiently and safely.<br></div> | ||
<center> | <center> | ||
− | <a href="/Team:Tongji_China/Model"><button class="homePageButton">Dry Lab</button></a> | + | <a href="/Team:Tongji_China/Model"><button class="homePageButton"style="background-color:#98B2D2;">Dry Lab</button></a> |
− | <a href="/Team:Tongji_China/WetLab"><button class="homePageButton">Wet Lab</button></a> | + | <a href="/Team:Tongji_China/WetLab"><button class="homePageButton"style="background-color:#EEC778;">Wet Lab</button></a> |
− | <a href="/Team:Tongji_China/Safety"><button class="homePageButton">Safety</button></a> | + | <a href="/Team:Tongji_China/Safety"><button class="homePageButton"style="background-color:#A8A96B;">Safety</button></a> |
</center> | </center> | ||
</div> | </div> | ||
Line 91: | Line 90: | ||
<br>to popularize our project idea.</div> | <br>to popularize our project idea.</div> | ||
<center> | <center> | ||
− | <a href="/Team:Tongji_China/Human_Practices"><button class="homePageButton">HP</button></a> | + | <a href="/Team:Tongji_China/Human_Practices"><button class="homePageButton"style="background-color:#BC818D;">HP</button></a> |
</center> | </center> | ||
Line 103: | Line 102: | ||
<br>collaborations with other iGEMers.</div> | <br>collaborations with other iGEMers.</div> | ||
<center> | <center> | ||
− | <a href="/Team:Tongji_China/Team"><button class="homePageButton">Team</button></a> | + | <a href="/Team:Tongji_China/Team"><button class="homePageButton"style="background-color:#6B98AA;">Team</button></a> |
− | <a href="/Team:Tongji_China/Collaborations"><button class="homePageButton">Collaborations</button></a> | + | <a href="/Team:Tongji_China/Collaborations"><button class="homePageButton"style="background-color:#98B2D2;">Collaborations</button></a> |
</center><br><br><br><br><br> | </center><br><br><br><br><br> | ||
Revision as of 16:38, 16 October 2018
Welcome to
Tongji_China
We focus our attention on
cancer therapy and T3SS to
create a new method to
present the promising individual
cancer antigen -“Neoantigen”.
cancer therapy and T3SS to
create a new method to
present the promising individual
cancer antigen -“Neoantigen”.
We use the bioinformatic method
to filter our item antigens and
use the T3SS in P. aeruginosa to deliver
them to the T cells through
oral intake.
to filter our item antigens and
use the T3SS in P. aeruginosa to deliver
them to the T cells through
oral intake.
We filter the antigens of interest.
Then we conduct the experiments
to prove that our system can work
efficiently and safely.
Then we conduct the experiments
to prove that our system can work
efficiently and safely.